They are very fast in neutralizing any molecule with the potential of developing into a free radical or any free radical with the ability to induce the production of other radicals
OLeary et al., using diagnostic codes, found that GLP-1 RA (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide) use was associated with a reduction in the odds of visual loss: at 6 months, OR 0.423 (95% CI 0.3240.546), and at 1 year, OR 0.606 (0.4890.747), compared to matched controls [37]
Some products should be ceased at least two weeks before any elective surgery, please confirm with your health professional
Body weight-based dosing around 4-6mcg per kilogram provides individualized starting points